Hibernoma
Hibernoma is a very rare benign soft tissue tumor that arises from fetal brown fat, the type of fat responsible for heat production (thermogenesis) in newborns and hibernating animals. It is characterized by multivacuolar fat cells filled with many small lipid droplets and abundant granular, eosinophilic cytoplasm (reflecting a very high density of mitochondria), mixed with mature univacuolar fat cells.
The "brown fat" label and the multivacuolar appearance of the tumor cells can easily cause confusion, both on imaging (strong 18F-FDG uptake on PET-CT due to high metabolic activity) and on histology, with myxoid liposarcoma, well-differentiated liposarcoma or rhabdomyoma. Despite its intense energy metabolism and rich blood supply, hibernoma is entirely benign. It usually appears in young adults (aged 20–40) on the back of the neck, shoulder, armpit, upper back or thigh, and is cured in 100% of cases by complete surgical removal.
At Haute-Derma, we manage hibernoma with a comprehensive medical pathway: dedicated histopathology with an immunohistochemistry panel (UCP1/S100/CD34/MDM2), detailed 3.0T MRI, and microsurgical removal of the tumor with its capsule intact, so the lesion is fully treated and patients can be confident in the outcome.
Clinical Features and Pathologic Classification
Causes and Molecular Genetics
- Brown fat biology and the differentiation protein UCP1 (uncoupling protein 1):
- Unlike white fat, which stores energy, brown fat is packed with mitochondria carrying the protein UCP1 (thermogenin) on their inner membrane. This protein releases energy as heat instead of producing ATP.
- Strong UCP1 positivity on immunohistochemistry is the biological gold standard for confirming hibernoma.
- Characteristic genetic change (11q13–21 rearrangement): Hibernoma is closely associated with chromosomal rearrangements at 11q13–21, which lead to reduced expression or mutation of tumor suppressor genes such as MEN1 (multiple endocrine neoplasia type 1) and GARP.
- Epidemiology and typical sites:
- Most common in young adults aged 20–40 (men and women equally affected, or slightly more men).
- Preferred sites: back of the neck, shoulder, armpit, the area between the shoulder blades (interscapular region), upper back, thigh and retroperitoneum.
Microscopic Findings (Histopathology, the Gold Standard)
Hibernoma has a highly distinctive histology, with three components arranged in lobules:
- Multivacuolar brown fat cells (the core cell type):
- Round or polygonal, medium-sized cells with strongly eosinophilic (pink), granular cytoplasm due to their very high mitochondrial content.
- The cytoplasm contains numerous small lipid droplets evenly arranged around a round, central nucleus (the nucleus is not flattened or pushed to the edge).
- Mature univacuolar adipocytes: scattered among the brown fat cells.
- Dense vascular network: the tumor is fed by a rich capillary network, which explains the typical gray-brown or red-brown color of the surgical specimen.
- Histologic variants: classic, lipoma-like, myxoid and spindle cell variants.
Differential Diagnosis and Immunohistochemistry (IHC)
Hibernoma is one of the tumors most easily misread on PET-CT (because of its high, misleading FDG uptake) and on biopsy:
| Condition | Immunohistochemical markers (IHC) | Distinguishing microscopic features |
|---|---|---|
| Hibernoma | UCP1 strongly (+); S100 (+); CD34 (+/-); MDM2 (-); CDK4 (-) | Multivacuolar cells with round central nuclei; eosinophilic, mitochondria-rich cytoplasm; no malignant lipoblasts. |
| Well-differentiated liposarcoma (WDLPS) | MDM2 (+); CDK4 (+); MDM2 gene amplification (+) | Malignant lipoblasts with atypical, hyperchromatic nuclei pushed to the periphery; atypical fibrous bands; UCP1 (-). |
| Myxoid liposarcoma | FUS-DDIT3 (+); UCP1 (-) | "Chicken-wire" capillary network; malignant lipoblasts in a myxoid background; UCP1 (-). |
| Rhabdomyoma | Desmin (+); myogenin (+); MyoD1 (+); UCP1 (-) | Large polygonal cells with abundant granular eosinophilic cytoplasm, sometimes finely vacuolated; cross-striations and rod-like crystals; no lipoblasts. |
Our Approach to Treating Hibernoma
Haute-Derma manages hibernoma on three principles: confirmation by UCP1 immunohistochemistry, precise localization with high-resolution 3.0T MRI, and microsurgical excision of the tumor with its capsule intact:
- Confirming benign nature with UCP1 (+) and MDM2 (-): Identifying the brown fat marker UCP1 (+) and confirming MDM2 (-) rules out liposarcoma completely. This removes patients' worry when the tumor shows "intense FDG uptake" on PET-CT.
- Complete encapsulated microsurgical excision: Hibernoma has a well-defined fibrous capsule and a rich blood supply. Meticulous microsurgical dissection with active control of bleeding removes the whole tumor and achieves a 100% cure rate.
- Optimal microsurgical hemostasis: Because the tumor has a dense capillary supply, the surgeon uses an ultrasonic scalpel or microsurgical bipolar device for thorough hemostasis, minimizing fluid collection after surgery.
How We Diagnose Hibernoma at Haute-Derma
- Clinical examination and symptom assessment: We assess soft tissue lumps on the back of the neck, shoulder, armpit, back or thigh in young adults. The lump is slightly firm, mobile and grows slowly; some patients notice that the skin over it feels "slightly warm" because of the heat-producing nature of brown fat.
- Imaging with 3.0T MRI / PET-CT:
- 3.0T MRI: the tumor shows intermediate-to-high signal on T1-weighted images (lower than ordinary white fat) and high signal on T2-weighted images, with strong contrast enhancement due to its rich vascularity.
- PET-CT (if performed): the tumor takes up 18F-FDG very intensely, mimicking a malignant lesion, so biopsy with IHC is required to confirm UCP1 (+).
- Core needle biopsy with mandatory IHC: Biopsy tissue is examined on H&E staining (to identify multivacuolar fat cells with central nuclei) together with an immunohistochemistry panel of UCP1, S100, MDM2 and CDK4 to confirm the diagnosis.
Specialized Treatment at Haute-Derma
- Microsurgical enucleation/excision with the capsule intact:
- Indication: the gold-standard treatment for hibernoma.
- Technique: a minimal incision is made along the natural skin creases (Langer's lines) of the neck, shoulder or armpit. The surgeon carefully separates the tumor's fibrous capsule from the surrounding healthy fat and muscle fascia, dividing and sealing the feeding vessels with a microsurgical bipolar device.
- Layered microsurgical closure and aesthetic wound care: The subcutaneous layers are sutured to close the dead space and prevent blood or fluid collection. Anti-inflammatory He-Ne laser and fractional CO2 laser are used to minimize the surgical scar.
- Follow-up: an ultrasound check at 6 months. Because the tumor is 100% benign, no additional treatment or cancer surveillance is needed.
